Revealing the pattern for next generation diagnostics

Biosignatures are developing next generation molecular diagnostic tests to arm clinicians and healthcare providers with accurate tools for the diagnosis of disease where current tools are invasive, expensive or both.

Biosignatures have made a major breakthrough in the application of the science of proteomics to the discovery of diagnostic products, and have several products performing well in clinical trials.

  • Participants

    If you're participating in one of the studies Biosignatures is running, thank you!

    This is where you can access the documents and find out more about what we're trying to achieve.

    participants
  • Clinicians

    Access to information for participating clinicians.

    This section describes the protocols used in the product development studies.

    clinicians
  • Business Development

    Click here to find out more about commercial partnering opportunities with Biosignatures.

    (This part of the website requires a login but also describes how to obtain one.)

    business development

An ISO 9001:2008 & ISO 13485:2003 certified company (see latest press release)

ISO 9001:2008 ISO 13485:2003